Book contents
- Individualized In-Vitro Fertilization
- Individualized In-Vitro Fertilization
- Copyright page
- Contents
- Contributors
- Chapter 1 Individualized Ovarian Stimulation for Normal and High Responders
- Chapter 2 Individualized Ovarian Stimulation in Patients with Advanced Maternal Age and Premature Ovarian Aging
- Chapter 3 Individualized Oocyte Maturation
- Chapter 4 Individualized Luteal Phase Support
- Chapter 5 Individualized Management of Male Infertility
- Chapter 6 Individualized Fertilization Technique in the IVF Laboratory
- Chapter 7 Individualized Genetic Testing
- Chapter 8 Individualized Embryo Selection
- Chapter 9 Preparation for Optimal Endometrial Receptivity in Cryo Cycles
- Chapter 10 Individualized Immunological Testing in Recurrent Implantation Failure
- Chapter 11 Individualized Embryo Transfer
- Index
- Plate Section (PDF Only)
- References
Chapter 1 - Individualized Ovarian Stimulation for Normal and High Responders
Published online by Cambridge University Press: 12 February 2021
Book contents
- Individualized In-Vitro Fertilization
- Individualized In-Vitro Fertilization
- Copyright page
- Contents
- Contributors
- Chapter 1 Individualized Ovarian Stimulation for Normal and High Responders
- Chapter 2 Individualized Ovarian Stimulation in Patients with Advanced Maternal Age and Premature Ovarian Aging
- Chapter 3 Individualized Oocyte Maturation
- Chapter 4 Individualized Luteal Phase Support
- Chapter 5 Individualized Management of Male Infertility
- Chapter 6 Individualized Fertilization Technique in the IVF Laboratory
- Chapter 7 Individualized Genetic Testing
- Chapter 8 Individualized Embryo Selection
- Chapter 9 Preparation for Optimal Endometrial Receptivity in Cryo Cycles
- Chapter 10 Individualized Immunological Testing in Recurrent Implantation Failure
- Chapter 11 Individualized Embryo Transfer
- Index
- Plate Section (PDF Only)
- References
Summary
Despite the notion that the first baby, Louise Brown, was born in 1978 following IVF performed in a natural menstrual cycle, ovarian stimulation became the golden standard of care in clinical IVF, since the number of oocytes retrieved is directly associated with pregnancy and life birth rates (, ). The aim should be to titrate the stimulation in such a way that the optimal number of follicles develops. Too few follicles (also referred to as low response) usually means poor IVF outcome, whereas too many developing follicles induce a risk for developing OHSS and possibly reduce the chance of success with increasing number of oocytes, if stimulation is not adjusted toward the end of the follicular phase (, ).
- Type
- Chapter
- Information
- Individualized In-Vitro FertilizationDelivering Precision Fertility Treatment, pp. 1 - 13Publisher: Cambridge University PressPrint publication year: 2021
References
Doody, K, Griesinger, G, Witjes, H, et al. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod 2013;28(2):442–452. doi:10.1093/humrep/des389.Google Scholar
Sunkara, SK, Rittenberg, V, Raine-Fenning, N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011;26:1768–1774.CrossRefGoogle ScholarPubMed
Lawrenz, B, Labarta, E, Fatemi, H, et al. Premature progesterone elevation: targets and rescue strategies. Fertil Steril 2018;109(4):577–582. doi:10.1016/j.fertnstert.2018.02.128.CrossRefGoogle ScholarPubMed
Mourad, S, Brown, J, Farquhar, C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev 2017;1:CD012103.Google ScholarPubMed
Muasher, SJ, Oehninger, S, Simonetti, S, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307.CrossRefGoogle ScholarPubMed
Niederberger, C, Pellicer, A, Cohen, J, et al. Forty years of IVF. Fertil Steril 2018;15(2):185–324e5. doi:10.1016/j.fertnstert.2018.06.005.Google Scholar
Broekmans, FJ, Kwee, J, Hendriks, DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685–718.CrossRefGoogle ScholarPubMed
Gleicher, N, Kushnir, VA, Sen, A, et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med 2016;14:172. doi:10.1186/s12967-016-0924-7.CrossRefGoogle ScholarPubMed
Fleming, R, Seifer, D, Frattarelli, J, et al. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod BioMed Online 2015;31:486–496. doi:10.1016/j.rbmo.2015.06.015.CrossRefGoogle ScholarPubMed
Melado, L, Lawrenz, B, Bungum, L, et al. Anti-Müllerian hormone variability during ovarian stimulation for IVF: a novel approach to predict fertility treatment outcomes. J Reprod Biol Endocrinol 2018;2(1):33–34.Google Scholar
Melado, L, Lawrenz, B, Sibal, J, et al. Anti-Müllerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay. Front Endocrinol 2018;9:686. doi:10.3389/fendo.2018.00686.CrossRefGoogle ScholarPubMed
La Marca, A, Sunkara, SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 2014;1:124–140. doi:10.1093/humupd/dmt037.CrossRefGoogle Scholar
Ferraretti, A, La Marca, A, Fauser, BCJM, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26(7):1616–1624.CrossRefGoogle ScholarPubMed
Lensen, SF, Wilkinson, J, Leijdekkers, JA, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev 2018;2:CD012693. doi:10.1002/14651858.CD012693.pub2.Google ScholarPubMed
Polyzos, NP, Drakopoulos, P, Parra, J, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril 2018;110(4):661–670. doi:10.1016/j.fertnstert.2018.04.039.CrossRefGoogle Scholar
Orvieto, R, Vanni, VS, Gleicher, N. The myths surrounding mild stimulation in vitro fertilization (IVF). Reprod Biol Endocrinol 2017;15(1):48. doi:10.1186/s12958-017-0266-1.CrossRefGoogle ScholarPubMed
Labarta, E, Bosch, E, Alama, P, et al. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab 2012;97:1987–1994.CrossRefGoogle Scholar
Gleicher, N, Kim, A, Weghofer, A, et al. Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol 2012;10:48.CrossRefGoogle ScholarPubMed
Fatemi, HM, Doody, K, Griesinger, G, et al. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod 2013;28:442–452. doi:10.1093/humrep/des389.CrossRefGoogle ScholarPubMed
García-Velasco, JA, Fatemi, HM. To pill or not to pill in GnRH antagonist cycles: that is the question! Reprod Biomed Online 2015;30(1):39–42. doi:10.1016/j.rbmo.2014.09.010.CrossRefGoogle ScholarPubMed
Lawrenz, B, Beligotti, F, Engelmann, N, et al. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod 2016;31:2554–2560.CrossRefGoogle ScholarPubMed
Lawrenz, B, Fatemi, H. Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity. Reprod Biomed Online 2017;34:422–428.CrossRefGoogle ScholarPubMed
Fatemi, HM, García-Velasco, JA. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril 2015;103:870–873.CrossRefGoogle ScholarPubMed
Popovic-Todorovic, B, Santos-Ribeiro, S, Drakopoulos, P, et al. Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation. Hum Reprod 2019;27. doi:10.1093/humrep/dez132.Google Scholar
Jeppesen, JV, Kristensen, SG, Nielsen, ME, et al. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab 2012;97(8):E1524–1531. doi:10.1210/jc.2012-1427.CrossRefGoogle ScholarPubMed